Viatris Inc
NASDAQ:VTRS
Viatris Inc
NASDAQ:VTRS
Price:
10.47 USD
0.48%
Market Closed
Updated:
Jun 9, 2024
Viatris Inc
Total Equity
|
Viatris Inc
Total Equity Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Viatris Inc
NASDAQ:VTRS
|
Total Equity
$20B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
11%
|
CAGR 10-Years
20%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Equity
$70B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-1%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Equity
$16.5B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
2%
|
CAGR 10-Years
1%
|
|
|
Pfizer Inc
NYSE:PFE
|
Total Equity
$92.3B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
2%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Total Equity
$40.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-2%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Equity
$12.8B
|
CAGR 3-Years
23%
|
CAGR 5-Years
39%
|
CAGR 10-Years
-4%
|
See Also
What is Viatris Inc's Total Equity?
Total Equity
20B
USD
20B
USD
Based on the financial report for Mar 31, 2024, Viatris Inc's Total Equity amounts to 20B USD.
What is Viatris Inc's Total Equity growth rate?
Total Equity CAGR 10Y
20%
20%
Over the last year, the Total Equity growth was -4%. The average annual Total Equity growth rates for Viatris Inc have been -2% over the past three years , 11% over the past five years , and 20% over the past ten years .
You don't have any saved screeners yet
